It won't be the only focus
From the company update on 20 august:
"Exploit the best opportunities from its current biotechnology intellectual property, specifically the
“Oraline” series.
Add additional biotechnology assets and potentially attract high calibre, experienced biotechnology
talent to the Company in the process."
- Forums
- ASX - By Stock
- SBN
- a bit more on howard digby
a bit more on howard digby, page-2
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SBN (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online